Key result
Recent advances highlight the mechanisms of transcriptional and post-transcriptional regulation of PKG-I expression in vascular smooth muscle cells and its role in cardiovascular diseases.
This review highlights the mechanisms of PKG-I down-regulation in vascular smooth muscle cells and its role in vascular injury and cardiovascular diseases.
Answers are grounded in this paper and cite their sources.
May inform PKG-I targeted therapies in vascular disease; leaves open clinical validation in prospective trials.
The ability of the endothelium to produce nitric oxide, which induces generation of cyclic guanosine monophosphate (cGMP) that activates cGMP-dependent protein kinase (PKG-I), in vascular smooth muscle cells (VSMCs), is essential for the maintenance of vascular homeostasis. Yet, disturbance of this nitric oxide/cGMP/PKG-I pathway has been shown to play an important role in many cardiovascular diseases. In the last two decades, in vitro and in vivo models of vascular injury have shown that PKG-I is suppressed following nitric oxide, cGMP, cytokine, and growth factor stimulation. The molecular basis for these changes in PKG-I expression is still poorly understood, and they are likely to be mediated by a number of processes, including changes in gene transcription, mRNA stability, protein synthesis, or protein degradation. Emerging studies have begun to define mechanisms responsible for changes in PKG-I expression and have identified cis- and trans-acting regulatory elements, with a plausible role being attributed to post-translational control of PKG-I protein levels. This review will focus mainly on recent advances in understanding of the regulation of PKG-I expression in VSMCs, with an emphasis on the physiological and pathological significance of PKG-I down-regulation in VSMCs in certain circumstances.
No takes yet. Share an insight, caveat, or question.
Sellak et al. (2012) conducted a review in Cardiovascular diseases. PKG-I regulation was evaluated. Recent advances highlight the mechanisms of transcriptional and post-transcriptional regulation of PKG-I expression in vascular smooth muscle cells and its role in cardiovascular diseases.
Synapse has enriched 10 related papers. Consider them for comparative context: